10-Q 1 d698978d10q.htm 10-Q 10-Q

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 1, 2014

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 001-09225

 

 

H.B. FULLER COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Minnesota   41-0268370

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1200 Willow Lake Boulevard, St. Paul, Minnesota   55110-5101
(Address of principal executive offices)   (Zip Code)

(651) 236-5900

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   x    Accelerated filer   ¨
Non-accelerated filer   ¨ (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x

The number of shares outstanding of the Registrant’s Common Stock, par value $1.00 per share, was 50,097,024 as of March 20, 2014.

 

 

 


PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(In thousands, except per share amounts)

(Unaudited)

 

     13 Weeks Ended  
     March 1,     March 2,  
     2014     2013  

Net revenue

   $ 485,981     $ 479,842  

Cost of sales

     (352,936     (346,466
  

 

 

   

 

 

 

Gross profit

     133,045       133,376  

Selling, general and administrative expenses

     (96,799     (97,640

Special charges, net

     (11,734     (5,333

Other income (expense), net

     (1,050     378  

Interest expense

     (4,126     (5,327
  

 

 

   

 

 

 

Income before income taxes and income from equity method investments

     19,336       25,454  

Income taxes

     (6,541     (7,120

Income from equity method investments

     1,854       2,440  
  

 

 

   

 

 

 

Net income including non-controlling interests

     14,649       20,774  

Net income attributable to non-controlling interests

     (78     (97
  

 

 

   

 

 

 

Net income attributable to H.B. Fuller

   $ 14,571     $ 20,677  
  

 

 

   

 

 

 

Earnings per share attributable to H.B. Fuller common stockholders:

    

Basic

   $ 0.29     $ 0.42  

Diluted

   $ 0.28     $ 0.41  

Weighted-average common shares outstanding:

    

Basic

     49,910       49,817  

Diluted

     51,255       51,027  

Dividends declared per common share

   $ 0.100     $ 0.085  

See accompanying Notes to Condensed Consolidated Financial Statements.

 

2


H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

 

     13 Weeks Ended  
     March 1,      March 2,  
     2014      2013  

Net income including non-controlling interests

   $ 14,649      $ 20,774  

Other comprehensive income (loss)

     

Foreign currency translation

     547        (3,462

Defined benefit pension plans adjustment, net of tax

     1,018        1,976  

Interest rate swaps, net of tax

     10        10  

Cash-flow hedges, net of tax

     3        210  
  

 

 

    

 

 

 

Other comprehensive income (loss)

     1,578        (1,266
  

 

 

    

 

 

 

Comprehensive income

     16,227        19,508  

Less: Comprehensive income attributable to non-controlling interests

     67        104  
  

 

 

    

 

 

 

Comprehensive income attributable to H.B. Fuller

   $ 16,160      $ 19,404  
  

 

 

    

 

 

 

See accompanying Notes to Condensed Consolidated Financial Statements.

 

3


H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except share and per share amounts)

(Unaudited)

 

     March 1,     November 30,  
     2014     2013  

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 113,047     $ 155,121  

Trade receivables (net of allowances - $8,991 and $8,539, for March 1, 2014 and November 30, 2013, respectively)

     327,314       331,125  

Inventories

     260,763       221,537  

Other current assets

     98,510       85,046  

Current assets of discontinued operations

     1,865       1,865  
  

 

 

   

 

 

 

Total current assets

     801,499       794,694  
  

 

 

   

 

 

 

Property, plant and equipment

     1,069,069       1,032,792  

Accumulated depreciation

     (606,697     (598,405
  

 

 

   

 

 

 

Property, plant and equipment, net

     462,372       434,387  
  

 

 

   

 

 

 

Goodwill

     265,444       263,103  

Other intangibles, net

     214,568       219,401  

Other assets

     165,224       161,443  
  

 

 

   

 

 

 

Total assets

   $ 1,909,107     $ 1,873,028  
  

 

 

   

 

 

 

Liabilities, redeemable non-controlling interest and total equity

    

Current liabilities:

    

Notes payable

   $ 21,846     $ 20,589  

Trade payables

     208,099       201,575  

Accrued compensation

     53,802       76,218  

Income taxes payable

     13,115       10,830  

Other accrued expenses

     50,238       46,566  

Current liabilities of discontinued operations

     5,000       5,000  
  

 

 

   

 

 

 

Total current liabilities

     352,100       360,778  
  

 

 

   

 

 

 

Long-term debt, excluding current maturities

     511,851       472,315  

Accrued pension liabilities

     52,135       52,922  

Other liabilities

     54,151       51,835  
  

 

 

   

 

 

 

Total liabilities

     970,237       937,850  
  

 

 

   

 

 

 

Commitments and contingencies

     —          —     

Redeemable non-controlling interest

     4,862       4,717  

Equity:

    

H.B. Fuller stockholders’ equity:

    

Preferred stock (no shares outstanding) Shares authorized – 10,045,900

     —          —     

Common stock, par value $1.00 per share, Shares authorized – 160,000,000, Shares outstanding – 50,074,010 and 50,228,543, for March 1, 2014 and November 30, 2013, respectively

     50,074       50,229  

Additional paid-in capital

     37,076       44,490  

Retained earnings

     916,838       907,308  

Accumulated other comprehensive income (loss)

     (70,373     (71,962
  

 

 

   

 

 

 

Total H.B. Fuller stockholders’ equity

     933,615       930,065  
  

 

 

   

 

 

 

Non-controlling interests

     393       396  
  

 

 

   

 

 

 

Total equity

     934,008       930,461  
  

 

 

   

 

 

 

Total liabilities, redeemable non-controlling interest and total equity

   $ 1,909,107     $ 1,873,028  
  

 

 

   

 

 

 

See accompanying Notes to Condensed Consolidated Financial Statements.

 

4


H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Statements of Total Equity

(In thousands)

(Unaudited)

 

     H.B. Fuller Company Shareholders              
     Common
Stock
    Additional
Paid-in
Capital
    Retained
Earnings
    Accumulated
Other
Comprehensive
Income (Loss)
    Non-
Controlling
Interests
    Total  

Balance at December 1, 2012

   $ 49,903     $ 37,965     $ 830,031     $ (139,626   $ 425     $ 778,698  

Comprehensive income

         96,761       67,664       370       164,795  

Dividends

         (19,484         (19,484

Stock option exercises

     462       8,429             8,891  

Share-based compensation plans other, net

     301       12,621             12,922  

Excess tax benefit on share-based compensation

       2,676             2,676  

Repurchases of common stock

     (437     (17,201           (17,638

Redeemable non-controlling interest

             (399     (399
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at November 30, 2013

     50,229       44,490       907,308       (71,962     396       930,461  

Comprehensive income

         14,571       1,589       67       16,227  

Dividends

         (5,041         (5,041

Stock option exercises

     94       1,911             2,005  

Share-based compensation plans other, net

     65       4,095             4,160  

Excess tax benefit on share-based compensation

       1,613             1,613  

Repurchases of common stock

     (314     (15,033           (15,347

Redeemable non-controlling interest

             (70     (70
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at March 1, 2014

   $ 50,074     $ 37,076     $ 916,838     $ (70,373   $ 393     $ 934,008  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying Notes to Condensed Consolidated Financial Statements.

 

5


H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

     13 Weeks Ended  
     March 1, 2014     March 2, 2013  

Cash flows from operating activities from continuing operations:

    

Net income including non-controlling interests

   $ 14,649     $ 20,774  

Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities from continuing operations:

    

Depreciation

     10,353       10,136  

Amortization

     5,775       5,507  

Deferred income taxes

     14       186  

Income from equity method investments

     (1,854     (2,440

Share-based compensation

     3,985       3,320  

Excess tax benefit from share-based compensation

     (1,613     (1,804

Change in assets and liabilities, net of effects of acquisitions and discontinued operations:

    

Trade receivables, net

     3,749       11,324  

Inventories

     (38,735     (22,913

Other assets

     (11,978     (7,617

Trade payables

     17,265       1,316  

Accrued compensation

     (22,837     (18,612

Other accrued expenses

     3,452       (2,382

Income taxes payable

     1,754       (9,130

Accrued / prepaid pensions

     (2,291     (2,428

Other liabilities

     1,359       (3,236

Other

     (155     6,515  
  

 

 

   

 

 

 

Net cash used in operating activities from continuing operations

     (17,108     (11,484

Cash flows from investing activities from continuing operations:

    

Purchased property, plant and equipment

     (50,879     (19,598

Purchased businesses

     —         1,625  

Proceeds from sale of property, plant and equipment

     610       228  
  

 

 

   

 

 

 

Net cash used in investing activities from continuing operations

     (50,269     (17,745

Cash flows from financing activities from continuing operations:

    

Proceeds from long-term debt

     40,000       36,000  

Repayment of long-term debt

     —         (43,500

Net proceeds (repayments) from notes payable

     1,283       (289

Dividends paid

     (5,004     (4,273

Proceeds from stock options exercised

     2,005       3,774  

Excess tax benefit from share-based compensation

     1,613       1,804  

Repurchases of common stock

     (15,347     (2,256
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities from continuing operations

     24,550       (8,740

Effect of exchange rate changes

     753       738  
  

 

 

   

 

 

 

Net change in cash and cash equivalents from continuing operations

     (42,074     (37,231

Cash used in operating activities of discontinued operations

     —         (74
  

 

 

   

 

 

 

Net change in cash and cash equivalents

     (42,074     (37,305

Cash and cash equivalents at beginning of period

     155,121       200,436  
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 113,047     $ 163,131  
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

    

Dividends paid with company stock

   $ 37     $ 33  

Cash paid for interest, net of amount capitalized of $983 and $84 for the periods ended March 1, 2014 and March 2, 2013, respectively

   $ 3,898     $ 4,959  

Cash paid for income taxes, net of refunds

   $ 2,756     $ 11,960  

See accompanying Notes to Condensed Consolidated Financial Statements.

 

6


H.B. FULLER COMPANY AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Amounts in thousands, except share and per share amounts)

(Unaudited)

Note 1: Accounting Policies

The accompanying unaudited interim Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information necessary for a fair presentation of results of operations, comprehensive income, financial position, and cash flows in conformity with U.S. generally accepted accounting principles. In our opinion, the unaudited interim Condensed Consolidated Financial Statements reflect all adjustments of a normal recurring nature considered necessary for the fair presentation of the results for the periods presented. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole.

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from these estimates. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in our Annual Report on Form 10-K for the year ended November 30, 2013 as filed with the Securities and Exchange Commission.

Recently Adopted Accounting Pronouncements:

In February 2013, the FASB issued ASU No. 2013-02, “Comprehensive Income: Reporting of Amounts Reclassified out of AOCI” which further amended the disclosure requirements for comprehensive income. The update requires entities to disclose items reclassified out of accumulated other comprehensive income (AOCI) and into net income in a single location either in the notes to the Condensed Consolidated Financial Statements or parenthetically on the face of the Condensed Consolidated Statements of Income. The amendment is effective for fiscal years, and interim periods within those years, beginning after December 15, 2012 and is to be applied prospectively. We adopted the new requirements in the first quarter of our 2014 fiscal year. Since this update impacts disclosure requirements only, the adoption of this update did not have an impact on our condensed consolidated results of operations or financial condition.

In July 2013, the FASB issued ASU No. 2013-11, “Income Taxes: Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” which requires that an unrecognized tax benefit should be presented in the financial statements as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward when settlement in this manner is available under the law. This guidance is effective for fiscal years and interim periods beginning after December 15, 2013 which is our fiscal 2015 and will be applied on a prospective basis to all unrecognized tax benefits that exist at the effective date. We adopted the new requirements in the first quarter of our 2014 fiscal year as early adoption was permitted. The adoption of this update did not have a material impact on our condensed consolidated financial condition.

Note 2: Acquisitions and Divestitures

Acquisitions

Plexbond Quimica, S.A.: On June 6, 2013 we acquired Plexbond Quimica, S.A., a provider of chemical urethane adhesives and polyurethane resins based in Curitiba, Brazil. The acquisition was a stock purchase and encompassed all of Plexbond Quimica, S.A. business operations. The purchase price of $10,239 was funded through existing cash and was recorded in our Americas Adhesives operating segment.

The fair value measurement was preliminary at March 1, 2014 and November 30, 2013 subject to further review and final resolution of any purchase price adjustments. We expect the fair value measurement process to be finalized in the second quarter of 2014.

 

7


The following table summarizes the preliminary fair value measurement of the assets acquired and liabilities assumed as of the date of acquisition:

 

     Preliminary Valuation  
     March 1, 2014     November 30, 2013  

Current assets

   $ 5,179     $ 5,179  

Property, plant and equipment

     2,275       2,275  

Goodwill

     3,626       3,626  

Other intangibles

    

Customer relationships

     3,529       3,529  

Noncompetition agreements

     565       565  

Other assets

     608       608  

Current liabilities

     (3,684     (3,684

Other liabilities

     (1,859     (1,859
  

 

 

   

 

 

 

Total purchase price

   $ 10,239     $ 10,239  
  

 

 

   

 

 

 

Divestitures

Central America Paints: On August 6, 2012 we completed the sale of our Central America Paints business to Compania Global de Pinturas S.A., a company of Inversiones Mundial S.A. The assets and liabilities of this business are presented on the Condensed Consolidated Balance Sheets as assets and liabilities of discontinued operations. A portion of the cash proceeds was determined to be contingent consideration, pending resolution of purchase agreement contingencies. The contingent consideration was valued at fair value based on level 3 inputs. The contingent consideration was included in current liabilities of discontinued operations in the Condensed Consolidated Balance Sheets at March 1, 2014 and November 30, 2013 as we expect the purchase agreement contingencies to be resolved in 2014.

The major classes of assets and liabilities of discontinued operations as of March 1, 2014 and November 30, 2013 were as follows:

 

     March 1, 2014      November 30, 2013  

Other current assets

   $ 1,865      $ 1,865  
  

 

 

    

 

 

 

Current assets of discontinued operations

     1,865        1,865  

Other accrued expenses

   $ 5,000      $ 5,000  
  

 

 

    

 

 

 

Current liabilities of discontinued operations

     5,000        5,000  

Note 3: Accounting for Share-Based Compensation

Overview: We have various share-based compensation programs, which provide for equity awards including stock options, restricted stock shares, restricted stock units and deferred compensation. These equity awards fall under several plans and are described in detail in our Annual Report on Form 10-K for the year ended November 30, 2013. Starting in 2014 we will no longer grant restricted stock shares.

Grant-Date Fair Value: We use the Black-Scholes option-pricing model to calculate the grant-date fair value of an award. The fair value of options granted during the 13 weeks ended March 1, 2014 and March 2, 2013 were calculated using the following weighted average assumptions:

 

     13 Weeks Ended
     March 1, 2014   March 2, 2013

Expected life (in years)

   4.75   4.75

Weighted-average expected volatility

   34.20%   48.02%

Expected volatility

   34.17% - 37.06%   48.02%

Risk-free interest rate

   1.51%   0.73%

Expected dividend yield

   0.82%   0.86%

Weighted-average fair value of grants

   $14.23   $15.12

 

8


Expected life – We use historical employee exercise and option expiration data to estimate the expected life assumption for the Black-Scholes grant-date valuation. We believe that this historical data is currently the best estimate of the expected term of a new option. We use a weighted-average expected life for all awards.

Expected volatility – Volatility is calculated using our historical volatility for the same period of time as the expected life. We have no reason to believe that our future volatility will differ materially from the past.

Risk-free interest rate – The rate is based on the U.S. Treasury yield curve in effect at the time of the grant for the same period of time as the expected life.

Expected dividend yield – The calculation is based on the total expected annual dividend payout divided by the average stock price.

Expense Recognition: We use the straight-line attribution method to recognize share-based compensation expense for option awards with graded vesting and restricted stock share and restricted stock units with graded and cliff vesting. The amount of share-based compensation expense recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest.

Total share-based compensation expense of $3,985 and $3,320 was included in our Condensed Consolidated Statements of Income for the 13 weeks ended March 1, 2014 and March 2, 2013, respectively. All share-based compensation expense was recorded as selling, general and administrative expense. For the 13 weeks ended March 1, 2014 and March 2, 2013 there was $1,613 and $1,804 of excess tax benefit recognized, respectively.

As of March 1, 2014, there was $11,142 of unrecognized compensation costs related to unvested stock option awards, which is expected to be recognized over a weighted-average period of 2.1 years. Unrecognized compensation costs related to unvested restricted stock shares was $6,049 and unvested restricted stock units was $6,835, both of which are expected to be recognized over a weighted-average period of 1.9 years.

Share-based Activity

A summary of option activity as of March 1, 2014 and changes during the 13 weeks then ended is presented below:

 

           Weighted-  
           Average  
     Options     Exercise Price  

Outstanding at November 30, 2013

     2,429,961     $ 25.74  

Granted

     407,145       48.93  

Exercised

     (94,475     21.23  

Forfeited or cancelled

     (13,628     33.74  
  

 

 

   

 

 

 

Outstanding at March 1, 2014

     2,729,003     $ 29.32  

The total fair values of options granted during the 13 weeks ended March 1, 2014 and March 2, 2013 were $5,793 and $6,546, respectively. Total intrinsic values of options exercised during the 13 weeks ended March 1, 2014 and March 2, 2013 were $2,673 and $4,200, respectively. Intrinsic value is the difference between our closing stock price on the respective trading day and the exercise price, multiplied by the number of options exercised. Proceeds received from option exercises during the 13 weeks ended March 1, 2014 and March 2, 2013 were $2,005 and $3,774, respectively.

 

9


A summary of nonvested restricted stock as of March 1, 2014 and changes during the 13 weeks then ended is presented below:

 

                              Weighted-  
                       Weighted-      Average  
                       Average      Remaining  
                       Grant      Contractual  
                       Date Fair      Life  
     Units     Shares     Total     Value      (in Years)  

Nonvested at November 30, 2013

     135,231       312,445       447,676     $ 33.76        1.2  

Granted

     120,094       —         120,094       48.94        1.9  

Vested

     (65,671     (106,036     (171,707     48.28        —    

Forfeited

     (335     (4,594     (4,929     35.17        1.5  
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Nonvested at March 1, 2014

     189,319       201,815       391,134     $ 40.11        1.7  

Total fair values of restricted stock vested during the 13 weeks ended March 1, 2014 and March 2, 2013 were $8,290 and $6,272, respectively. The total fair value of nonvested restricted stock at March 1, 2014 was $12,884.

We repurchased 64,063 and 59,652 restricted stock shares during the 13 weeks ended March 1, 2014 and March 2, 2013, respectively. The repurchases relate to statutory minimum tax withholding.

We have a Directors’ Deferred Compensation plan that allows non-employee directors to defer all or a portion of their directors’ compensation in a number of investment choices, including units representing shares of our common stock. We also have a Key Employee Deferred Compensation Plan that allows key employees to defer a portion of their eligible compensation in a number of investment choices, including units, representing shares of our common stock. We provide a 10 percent match on deferred compensation invested into units, representing shares of our common stock. A summary of deferred compensation units as of March 1, 2014, and changes during the 13 weeks then ended is presented below:

 

     Non-employee               
     Directors      Employees     Total  

Units outstanding November 30, 2013

     312,680        61,288       373,968  

Participant contributions

     3,139        644       3,783  

Company match contributions

     314        64       378  

Payouts

     —          (4,577     (4,577
  

 

 

    

 

 

   

 

 

 

Units outstanding March 1, 2014

     316,133        57,419       373,552  

Deferred compensation units are fully vested at the date of contribution.

Note 4: Earnings Per Share

A reconciliation of the common share components for the basic and diluted earnings per share calculations follows:

 

     13 Weeks Ended  
     March 1,      March 2,  

(Shares in thousands)

   2014      2013  

Weighted-average common shares - basic

     49,910        49,817  

Equivalent shares from share-based compensations plans

     1,345        1,210  
  

 

 

    

 

 

 

Weighted-average common and common equivalent shares - diluted

     51,255        51,027  
  

 

 

    

 

 

 

Basic earnings per share is calculated by dividing net income attributable to H.B. Fuller by the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per share is based upon the weighted-average number of common and common equivalent shares outstanding during the applicable period. The difference between basic and diluted earnings per share is attributable to share-based compensation awards. We use the treasury stock method to calculate the effect of outstanding shares, which computes total employee proceeds as the sum of (a) the amount the employee must pay upon exercise of the award, (b) the amount of unearned share-based compensation costs attributed to future services and (c) the amount of tax benefits, if any, that would be credited to additional paid-in capital assuming exercise of the award. Share-based compensation awards for which total employee proceeds exceed the average market price over the applicable period have an antidilutive effect on earnings per share, and accordingly, are excluded from the calculation of diluted earnings per share.

 

10


Options to purchase 407,145 shares of common stock at a weighted-average exercise price of $48.93 for the 13 weeks ended March 1, 2014, were excluded from the diluted earnings per share calculations because they were antidilutive. Our March 2, 2013 stock price was higher than any of our stock option grant prices at that time, therefore no option shares were excluded from the diluted earnings per share calculations for the first quarter of 2013.

Note 5: Accumulated Other Comprehensive Income (Loss)

The following table provides details of total comprehensive income (loss):

 

     13 Weeks Ended March 1, 2014     13 Weeks Ended March 2, 2013  
     H.B. Fuller Stockholders      Non-
controlling
Interests
    H.B. Fuller Stockholders     Non-
controlling
Interests
 
     Pretax      Tax     Net      Net     Pretax     Tax     Net     Net  

Net income including non-controlling interests

        $ 14,571      $ 78         $ 20,677     $ 97  

Other comprehensive income (loss)

                  

Foreign currency translation adjustment¹

   $ 558        —         558        (11   $ (3,469     —         (3,469     7  

Reclassification to earnings:

                  

Defined benefit pension plans adjustment²

     1,656        (638     1,018          3,042       (1,066     1,976    

Interest rate swap³

     14        (4     10          14       (4     10    

Cash-flow hedges³

     6        (3     3          342       (132     210    
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss)

   $ 2,234      $ (645     1,589        (11   $ (71   $ (1,202     (1,273     7  
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income

        $ 16,160      $ 67         $ 19,404     $ 104  
       

 

 

    

 

 

       

 

 

   

 

 

 

 

¹ Income taxes are not provided for foreign translation relating to permanent investments in international subsidiaries.
² Loss reclassified from AOCI into earnings as part of net periodic cost related to pension and other postretirement benefit plans is reported in cost of sales, SG&A and special charges.
³ Loss reclassified from AOCI into earnings is reported in other income (expense), net.

The components of accumulated other comprehensive income (loss) follow:

 

     March 1, 2014  
     Total     H.B. Fuller
Stockholders
    Non-
controlling
Interests
 

Foreign currency translation adjustment

   $ 50,418     $ 50,436     $ (18

Defined benefit pension plans adjustment, net of taxes of $64,572

     (120,637     (120,637     —    

Interest rate swap, net of taxes of $32

     (84     (84     —    

Cash-flow hedges, net of taxes of $54

     (88     (88     —    
  

 

 

   

 

 

   

 

 

 

Accumulated other comprehensive income (loss)

   $ (70,391   $ (70,373   $ (18
  

 

 

   

 

 

   

 

 

 

 

11


     November 30, 2013  
     Total     H.B. Fuller
Stockholders
    Non-
controlling
Interests
 

Foreign currency translation adjustment

   $ 49,871     $ 49,878     $ (7

Defined benefit pension plans adjustment, net of taxes of $65,210

     (121,655     (121,655     —    

Interest rate swap, net of taxes of $36

     (94     (94     —    

Cash-flow hedges, net of taxes of $57

     (91     (91     —    
  

 

 

   

 

 

   

 

 

 

Accumulated other comprehensive income (loss)

   $ (71,969   $ (71,962   $ (7
  

 

 

   

 

 

   

 

 

 

Note 6: Special Charges, net

The integration of the Forbo industrial adhesives business we acquired in March 2012 involves a significant amount of restructuring and capital investment to optimize the new combined entity. In addition, we are taking a series of actions in our existing EIMEA operating segment to improve the profitability and future growth prospects of this operating segment. We have combined these two initiatives into a single project which we refer to as the “Business Integration Project”. During the 13 weeks ended March 1, 2014 and March 2, 2013, we incurred special charges, net of $11,734 and $5,333, respectively for costs related to the Business Integration Project.

The following table provides detail of special charges, net:

 

     13 Weeks Ended  
     March 1, 2014      March 2, 2013  

Acquisition and transformation related costs

   $ 1,708      $ 2,282  

Workforce reduction costs

     2,059        484  

Facility exit costs

     5,126        1,789  

Other related costs

     2,841         778  
  

 

 

    

 

 

 

Special charges, net

   $ 11,734      $ 5,333  
  

 

 

    

 

 

 

Acquisition and transformation related costs of $1,708 for the 13 weeks ended March 1, 2014 and $2,282 for the 13 weeks ended March 2, 2013 include costs related to organization consulting, financial advisory and legal services necessary to integrate the Forbo industrial adhesives business into our existing operating segments. During the 13 weeks ended March 1, 2014, we incurred workforce reduction costs of $2,059, cash facility exit costs of $3,574 and non-cash facility exit costs of $1,552 and other incremental transformation related costs of $2,841 including the cost of personnel directly working on the integration. During the 13 weeks ended March 2, 2013, we incurred workforce reduction costs of $484, cash facility exit costs of $1,397 and non-cash facility exit costs of $392 and other incremental transformation related costs of $778 including the cost of personnel directly working on the integration.

For the 13 weeks ended March 1, 2014, the activity in accrued compensation associated with the Business Integration Project, is as follows:

 

     Workforce
Reduction Costs
 

Balance at November 30, 2013

   $ 18,057  

Workforce reduction costs

     2,059  

Cash payments

     (5,473

Foreign currency translation adjustment

     37  
  

 

 

 

Balance at March 1, 2014

   $ 14,680  
  

 

 

 

Of the $14,680 in accrued workforce reduction costs at March 1, 2014 $13,895 was included in accrued compensation and $785 was included in other liabilities on our Condensed Consolidated Balance Sheets as this portion was not expected to be paid within the next year. The benefits were accrued based primarily on the formal severance plans in place for the various locations. The restructuring costs are not allocated to our operating segments.

 

12


Note 7: Components of Net Periodic Cost (Benefit) related to Pension and Other Postretirement Benefit Plans

 

     13 Weeks Ended March 1, 2014 and March 2, 2013  
           Other  
     Pension Benefits     Postretirement  
     U.S. Plans     Non-U.S. Plans     Benefits  

Net periodic cost (benefit):

   2014     2013     2014     2013     2014     2013  

Service cost

   $ 23     $ 27     $ 430     $ 423     $ 108     $ 156  

Interest cost

     4,022       3,680       1,893       1,869       536       533  

Expected return on assets

     (5,966     (5,680     (2,690     (2,382     (1,186     (931

Amortization:

            

Prior service cost

     7       12       (1     (1     (943     (1,034

Actuarial (gain)/ loss

     1,144       1,685       772       951       677       1,429  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net periodic cost (benefit)

   $ (770   $ (276   $ 404     $ 860     $ (808   $ 153  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Note 8: Inventories

The composition of inventories follows:

 

     March 1,     November 30,  
     2014     2013  

Raw materials

   $ 134,717     $ 119,536  

Finished goods

     146,673       122,584  

LIFO reserve

     (20,627     (20,583
  

 

 

   

 

 

 

Total inventories

   $ 260,763     $ 221,537  
  

 

 

   

 

 

 

Note 9: Financial Instruments

As a result of being a global enterprise, our earnings, cash flows and financial position are exposed to foreign currency risk from foreign currency denominated receivables and payables. These items are denominated in various foreign currencies, including the Euro, British pound sterling, Canadian dollar, Chinese renminbi, Japanese yen, Australian dollar, Argentine peso, Brazilian real, Colombian peso, Mexican peso, Turkish lira, Egyptian pound, Indian rupee and Malaysian ringgit.

Our objective is to balance, where possible, local currency denominated assets to local currency denominated liabilities to have a natural hedge and minimize foreign exchange impacts. We take steps to minimize risks from foreign currency exchange rate fluctuations through normal operating and financing activities and, when deemed appropriate, through the use of derivative instruments. We do not enter into any speculative positions with regard to derivative instruments.

We enter into derivative contracts with a group of investment grade multinational commercial banks. We evaluate the credit quality of each of these banks on a periodic basis as warranted.

Effective March 5, 2012, we entered into two cross-currency swap agreements to convert a notional amount of $151,598 of foreign currency denominated intercompany loans into US dollars. One of the cross-currency swaps matures in 2014 and the other swap matures in 2015. As of March 1, 2014, the combined fair value of the swaps were a liability of $7,235 and were included in other liabilities in the Condensed Consolidated Balance Sheets. The swaps were designated as cash-flow hedges for accounting treatment. The lesser amount between the cumulative change in the fair value of the actual swaps and the cumulative change in the fair value of hypothetical swaps is recorded in accumulated other comprehensive income (loss) in the Condensed Consolidated Balance Sheets. The difference between the cumulative change in the fair value of the actual swaps and the cumulative change in the fair value of hypothetical swaps are recorded as other income (expense), net in the Condensed Consolidated Statements of Income. In a perfectly effective hedge relationship, the two fair value calculations would exactly offset each

 

13


other. Any difference in the calculation represents hedge ineffectiveness. The ineffectiveness calculations as of March 1, 2014 resulted in additional pre-tax loss of $25 year-to-date as the change in fair value of the cross-currency swaps was less than the change in the fair value of the hypothetical swaps. The amount in accumulated other comprehensive income (loss) related to cross-currency swaps was a loss of $88 at March 1, 2014. The estimated net amount of the existing loss that is reported in accumulated other comprehensive income (loss) at March 1, 2014 that is expected to be reclassified into earnings within the next twelve months is $88. At March 1, 2014, we believe the original forecasted transactions will occur, therefore, we do not believe any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges.

The following table summarizes the cross-currency swaps outstanding as of March 1, 2014:

 

     Fiscal Year of
Expiration
     Interest Rate     Notional Value      Fair Value  

Pay EUR

Receive USD

     2014       

 

4.15

4.30


  $ 52,860      $ (2,351

Pay EUR

Receive USD

     2015       

 

4.30

4.45


  $ 98,738      $ (4,884
       

 

 

    

 

 

 

Total

        $ 151,598      $ (7,235
       

 

 

    

 

 

 

Except for the two cross currency swap agreements listed above, foreign currency derivative instruments outstanding are not designated as hedges for accounting purposes. The gains and losses related to mark-to-market adjustments are recognized as other income or expense in the income statement during the periods in which the derivative instruments are outstanding. See Note 14 to Condensed Consolidated Financial Statements for fair value amounts of these derivative instruments.

As of March 1, 2014, we had forward foreign currency contracts maturing between March 7, 2014 and November 3, 2014. The mark-to-market effect associated with these contracts, on a net basis, was a loss of $379 at March 1, 2014. These losses were largely offset by the underlying transaction gains and losses resulting from the foreign currency exposures for which these contracts relate.

We have interest rate swap agreements to convert $75,000 of our Senior Notes to variable interest rates. The change in fair value of the Senior Notes, attributable to the change in the risk being hedged, was a liability of $5,607 at March 1, 2014 and was included in long-term debt in the Condensed Consolidated Balance Sheets. The fair values of the swaps in total were an asset of $5,527 at March 1, 2014 and were included in other assets in the Condensed Consolidated Balance Sheets. The swaps were designated for hedge accounting treatment as fair value hedges. The changes in the fair value of the swap and the fair value of the Senior Notes attributable to the change in the risk being hedged are recorded as other income (expense), net in the Condensed Consolidated Statements of Income. In a perfectly effective hedge relationship, the two fair value calculations would exactly offset each other. Any difference in the calculation represents hedge ineffectiveness. The calculation as of March 1, 2014 resulted in additional pre-tax gain of $55 year-to-date as the fair value of the interest rate swaps increased by more than the change in the fair value of the Senior Notes attributable to the change in the risk being hedged.

Concentrations of credit risk with respect to trade accounts receivable are limited due to the large number of entities in the customer base and their dispersion across many different industries and countries. As of March 1, 2014, there were no significant concentrations of credit risk.

Note 10: Commitments and Contingencies

Environmental Matters: From time to time, we become aware of compliance matters relating to, or receive notices from, federal, state or local entities regarding possible or alleged violations of environmental, health or safety laws and regulations. We review the circumstances of each individual site, considering the number of parties involved, the level of potential liability or contribution of us relative to the other parties, the nature and magnitude of the hazardous substances involved, the method and extent of remediation, the estimated legal and consulting expense with respect to each site and the time period over which any costs would likely be incurred. Also, from time to time, we are identified as a “potentially responsible party” (PRP) under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) and/or similar state laws that impose liability for costs relating to the clean up of contamination resulting from past spills, disposal or other release of hazardous substances. We are also

 

14


subject to similar laws in some of the countries where current and former facilities are located. Our environmental, health and safety department monitors compliance with applicable laws on a global basis. To the extent we can reasonably estimate the amount of our probable liabilities for environmental matters, we establish a financial provision.

Currently we are involved in various environmental investigations, clean up activities and administrative proceedings and lawsuits. In particular, we are currently deemed a PRP in conjunction with numerous other parties, in a number of government enforcement actions associated with landfills and/or hazardous waste sites. As a PRP, we may be required to pay a share of the costs of investigation and clean up of these sites. In addition, we are engaged in environmental remediation and monitoring efforts at a number of current and former operating facilities. While uncertainties exist with respect to the amounts and timing of the ultimate environmental liabilities, based on currently available information, we have concluded that these matters, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow.

Other Legal Proceedings: From time to time and in the ordinary course of business, we are a party to, or a target of, lawsuits, claims, investigations and proceedings, including product liability, personal injury, contract, patent and intellectual property, environmental, health and safety, tax and employment matters. While we are unable to predict the outcome of these matters, we have concluded, based upon currently available information, that the ultimate resolution of any pending matter, individually or in the aggregate, including the asbestos litigation described in the following paragraphs, will not have a material adverse effect on our results of operations, financial condition or cash flow.

We have been named as a defendant in lawsuits in which plaintiffs have alleged injury due to products containing asbestos manufactured more than 30 years ago. The plaintiffs generally bring these lawsuits against multiple defendants and seek damages (both actual and punitive) in very large amounts. In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable injuries or that the injuries suffered were the result of exposure to products manufactured by us. We are typically dismissed as a defendant in such cases without payment. If the plaintiff presents evidence indicating that compensable injury occurred as a result of exposure to our products, the case is generally settled for an amount that reflects the seriousness of the injury, the length, intensity and character of exposure to products containing asbestos, the number and solvency of other defendants in the case, and the jurisdiction in which the case has been brought.

A significant portion of the defense costs and settlements in asbestos-related litigation is paid by third parties, including indemnification pursuant to the provisions of a 1976 agreement under which we acquired a business from a third party. Currently, this third party is defending and paying settlement amounts, under a reservation of rights, in most of the asbestos cases tendered to the third party.

In addition to the indemnification arrangements with third parties, we have insurance policies that generally provide coverage for asbestos liabilities (including defense costs). Historically, insurers have paid a significant portion of our defense costs and settlements in asbestos-related litigation. However, certain of our insurers are insolvent. We have entered into cost-sharing agreements with our insurers that provide for the allocation of defense costs and under certain circumstances, settlements and judgments, in asbestos-related lawsuits. Under these agreements, we are required under certain circumstances to fund a share of settlements and judgments allocable to years in which the responsible insurer is insolvent. In addition, to delineate our rights under certain insurance policies, in October 2009, we commenced a declaratory judgment action against one of our insurers in the United States District Court for the District of Minnesota. Additional insurers have been brought into the action to address issues related to the scope of their coverage. We recently entered into a settlement agreement with the defendant insurers in this case that provided for the allocation of defense costs and settlements in the future. The allocation under the settlement agreement depends on the outcome of an appeal of two issues to the United States Eighth Circuit Court of Appeals.

A summary of the number of and settlement amounts for asbestos-related lawsuits and claims is as follows:

 

     13 Weeks Ended      3 Years Ended  

($ in thousands)

   March 1, 2014      March 2, 2013      November 30, 2013  

Lawsuits and claims settled

     2        —          22  

Settlement amounts

   $ 115      $ —        $ 1,448  

Insurance payments received or expected to be received

   $ 94      $ —        $ 1,087  

 

15


We do not believe that it would be meaningful to disclose the aggregate number of asbestos-related lawsuits filed against us because relatively few of these lawsuits are known to involve exposure to asbestos-containing products that we manufactured. Rather, we believe it is more meaningful to disclose the number of lawsuits that are settled and result in a payment to the plaintiff. To the extent we can reasonably estimate the amount of our probable liabilities for pending asbestos-related claims, we establish a financial provision and a corresponding receivable for insurance recoveries.

Based on currently available information, we have concluded that the resolution of any pending matter, including asbestos-related litigation, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow.

Note 11: Operating Segments

We are required to report segment information in the same way that we internally organize our business for assessing performance and making decisions regarding allocation of resources. We evaluate the performance of each of our operating segments based on segment operating income, which is defined as gross profit less selling, general and administrative (SG&A) expenses. Segment operating income excludes special charges, net. Corporate expenses are fully allocated to each operating segment. Inter-segment revenues are recorded at cost plus a markup for administrative costs. Operating results of each segment are regularly reviewed by our chief operating decision maker to make decisions about resources to be allocated to the segments and assess their performance.

Through the third quarter of 2013, our business was reported in five operating segments: North America Adhesives, EIMEA (Europe, India, Middle East and Africa), Latin America Adhesives, Asia Pacific and Construction Products. Changes in our management reporting structure during the fourth quarter of 2013 required us to conduct an operating segment assessment in accordance with ASC Topic 280 “Segment Reporting”, to determine our reportable segments. As a result of this assessment, we now have four reportable segments: Americas Adhesives, EIMEA, Asia Pacific and Construction Products. Prior periods have been restated to reflect our new operating segments.

The tables below provide certain information regarding net revenue and segment operating income of each of our operating segments:

 

     13 Weeks Ended  
     March 1, 2014      March 2, 2013  
            Inter-      Segment             Inter-      Segment  
     Trade      Segment      Operating      Trade      Segment      Operating  
     Revenue      Revenue      Income      Revenue      Revenue      Income  

Americas Adhesives

   $ 209,666      $ 5,680      $ 25,206      $ 207,731      $ 4,878      $ 25,925  

EIMEA

     171,559        4,106        8,440        177,501        2,676        6,473  

Asia Pacific

     65,047        3,471        1,788        60,579        3,492        1,974  

Construction Products

     39,709        272        812        34,031        81        1,364  
  

 

 

       

 

 

    

 

 

       

 

 

 

Total

   $ 485,981         $ 36,246      $ 479,842         $ 35,736  
  

 

 

       

 

 

    

 

 

       

 

 

 

Reconciliation of segment operating income to income before income taxes and income from equity method investments:

 

     13 Weeks Ended  
     March 1,     March 2,  
     2014     2013  

Segment operating income

   $ 36,246     $ 35,736  

Special charges, net

     (11,734     (5,333

Other income (expense), net

     (1,050     378  

Interest expense

     (4,126     (5,327
  

 

 

   

 

 

 

Income before income taxes and income from equity method investments

   $ 19,336     $ 25,454  
  

 

 

   

 

 

 

 

16


Note 12: Income Taxes

As of March 1, 2014, we had a $5,343 liability recorded under FASB ASC 740, “Income Taxes” for gross unrecognized tax benefits, excluding interest. As of March 1, 2014, we had accrued $790 of gross interest relating to unrecognized tax benefits. During the first quarter of 2014 our recorded liability for gross unrecognized tax benefits increased by $192.

Note 13: Goodwill

A summary of goodwill activity for the first three months of 2014 is presented below:

 

Balance at November 30, 2013

   $  263,103  

Currency impact

     2,341  
  

 

 

 

Balance at March 1, 2014

   $ 265,444  
  

 

 

 

Note 14: Fair Value Measurements

The following tables present information about our financial assets and liabilities that are measured at fair value on a recurring basis as of March 1, 2014 and November 30, 2013, and indicates the fair value hierarchy of the valuation techniques utilized to determine such fair value. The hierarchy is broken down into three levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs include data points that are observable such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) such as interest rates and yield curves that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.

 

     March 1,      Fair Value Measurements Using:  

Description

   2014      Level 1      Level 2      Level 3  

Assets:

           

Marketable securities

   $ 14,954      $ 14,954      $ —        $ —    

Derivative assets

     720        —          720        —     

Interest rate swaps

     5,527        —          5,527        —    

Liabilities:

           

Derivative liabilities

   $ 1,099      $ —        $ 1,099      $ —    

Cash-flow hedges

     7,235        —          7,235        —    

Contingent consideration liability, continuing operations

     563        —          —          563  

Contingent consideration liability, discontinued operations

     5,000        —          —          5,000  

 

     November 30,      Fair Value Measurements Using:  

Description

   2013      Level 1      Level 2      Level 3  

Assets:

           

Marketable securities

   $ 28,786      $ 28,786      $ —        $ —    

Derivative assets

     533        —          533        —     

Interest rate swaps

     5,930        —          5,930        —    

Liabilities:

           

Derivative liabilities

   $ 1,399      $ —        $ 1,399      $ —    

Cash-flow hedges

     4,801        —          4,801        —    

Contingent consideration liability, continuing operations

     566        —          —          566  

Contingent consideration liability, discontinued operations

     5,000        —          —          5,000  

 

17


Note 15: Share Repurchase Program

On September 30, 2010, the Board of Directors authorized a share repurchase program of up to $100,000 of our outstanding common shares. Under the program, we are authorized to repurchase shares for cash on the open market, from time to time, in privately negotiated transactions or block transactions, or through an accelerated repurchase agreement. The timing of such repurchases is dependent on price, market conditions and applicable regulatory requirements. Upon repurchase of the shares, we reduced our common stock for the par value of the shares with the excess being applied against additional paid-in capital.

During the first quarter of 2014 we repurchased shares under this program, with an aggregate value of $12,254. Of this amount, $250 reduced common stock and $12,004 reduced additional paid-in capital. There were no shares repurchased under this program during the first quarter of 2013.

Note 16: Redeemable Non-Controlling Interest

We account for the non-controlling interest in H.B. Fuller Kimya San. Tic A.S. (HBF Kimya) as a redeemable non-controlling interest because both the non-controlling shareholder and H.B. Fuller have an option, exercisable beginning August 1, 2018, to require the redemption of the shares owned by the non-controlling shareholder at a price determined by a formula based on 24 months trailing EBITDA. Since the option makes the redemption of the non-controlling ownership shares of HBF Kimya outside of our control, these shares are classified as a redeemable non-controlling interest in temporary equity in the Condensed Consolidated Balance Sheets. The non-controlling shareholder is entitled to increase his ownership by 1 percent per year for 5 years up to a maximum of 13 percent ownership based on the achievement of profitability targets in each year. The option is subject to a minimum price of €3,500. The redemption value of the option, if it were currently redeemable, is estimated to be €3,500.

HBF Kimya’s results of operations are consolidated in our financial statements. Both the non-controlling interest and the accretion adjustment to redemption value are included in net income attributable to non-controlling interests in the Condensed Consolidated Statements of Income and in the carrying value of the redeemable non-controlling interest on the Condensed Consolidated Balance Sheets. As of March 1, 2014 the redeemable non-controlling interest was:

 

Balance at November 30, 2013

   $ 4,717  

Net income attributed to redeemable non-controlling interest

     70  

Foreign currency translation adjustment

     75  
  

 

 

 

Balance at March 1, 2014

   $ 4,862  
  

 

 

 

 

18


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

The Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read in conjunction with the MD&A included in our Annual Report on Form 10-K for the year ended November 30, 2013 for important background information related to our business.

Net revenue in the first quarter of 2014 increased 1.3 percent over the first quarter of 2013. Sales volume increased 2.0 percent and pricing was flat compared to last year. The weakening of the Australian dollar, Canadian dollar, Turkish lira and Indian rupee for the first quarter of 2014 compared to the first quarter of 2013 were the main drivers of the negative 0.7 percent currency effect compared to the U.S. dollar. Gross profit margin decreased 40 basis points primarily driven by $1.3 million of business integration costs that are not classified as special charges. We incurred special charges, net of $11.7 million for costs related to the Business Integration Project in the first quarter of 2014 and $5.3 million in the first quarter of 2013.

Net income attributable to H.B. Fuller in the first quarter of 2014 was $14.6 million as compared to $20.7 million in the first quarter of 2013. On a diluted earnings per share basis, the first quarter of 2014 was $0.28 per share as compared to $0.41 per share for the same period last year.

Results of Operations

Net revenue:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
     March 2,
2013
     2014 vs
2013
 

Net revenue

   $ 486.0      $ 479.8        1.3

We review variances in net revenue in terms of changes related to product pricing, sales volume and changes in foreign currency exchange rates. The pricing/sales volume variance is viewed as organic growth. The following table shows the net revenue variance analysis for the first quarter of 2014 compared to the same period in 2013:

 

    

13 Weeks Ended March 1, 2014

 
     vs March 2, 2013  

Product pricing

     0.0

Sales volume

     2.0

Currency

     (0.7 %) 
  

 

 

 
     1.3
  

 

 

 

Organic growth was 2.0 percent in the first quarter of 2014 compared to the first quarter of 2013. Sales volume increased 2.0 percent and pricing was unchanged compared to last year. The 2.0 percent organic growth in 2014 was driven by 16.7 percent growth in Construction Products, 10.8 percent growth in Asia Pacific and 1.5 percent growth in Americas Adhesives. The majority of the currency impact was driven by the weakening of the Australian dollar, Canadian dollar, Indian rupee and Turkish lira compared to the U.S. dollar.

Cost of sales:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

Raw materials

   $ 275.1     $ 271.7       1.3

Other manufacturing costs

     77.8       74.8       4.0
  

 

 

   

 

 

   

Cost of sales

   $ 352.9     $ 346.5       1.8

Percent of net revenue

     72.6     72.2  

 

19


Cost of sales in the first quarter of 2014 compared to first quarter of 2013 increased 1.8 percent. Raw material cost as a percentage of net revenue was 56.6 percent for both years. Other manufacturing costs as a percentage of revenue increased by 40 basis points compared to last year mainly due to $1.3 million business integration costs that are not classified as special charges. As a result, cost of sales as a percentage of net revenue increased 40 basis points in the first quarter of 2014 compared to the same period last year.

Gross profit:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

Gross profit

   $ 133.0     $ 133.4       (0.2 %) 

Percent of net revenue

     27.4     27.8  

Gross profit in the first quarter of 2014 decreased by $0.4 million and gross profit margin decreased by 40 basis points compared to the first quarter of 2013. Business integration costs that are not classified as special charges were the primary reason for the decrease in gross profit.

Selling, general and administrative (SG&A) expenses:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

SG&A

   $ 96.8     $ 97.6       (0.9 %) 

Percent of net revenue

     19.9     20.3  

SG&A expenses for the first quarter of 2014 decreased $0.8 million or 0.9 percent compared to 2013. The 40 basis point decrease in SG&A expense as a percentage of net revenue was driven by effective cost controls and the ongoing benefits of the Business Integration Project.

We make SG&A expense plans at the beginning of each fiscal year and barring significant changes in business conditions or our outlook for the future, we maintain these spending plans for the entire year. Management routinely monitors our SG&A spending relative to these fiscal year plans for each operating segment and for the company overall. We feel it is important to maintain a consistent spending program in this area as many of the activities within the SG&A category such as the sales force, technology development, and customer service are critical elements of our business strategy. For the current year we planned SG&A expenses to increase relative to last year by an amount slightly less than our expected growth in net revenue.

Special charges, net:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
     March 2,
2013
     2014 vs
2013
 

Special charges, net

   $ 11.7      $ 5.3        120.0

The following table provides detail of special charges, net:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
     March 2,
2013
 

Acquisition and transformation related costs

   $ 1.7      $ 2.2  

Workforce reduction costs

     2.1        0.5  

Facility exit costs

     5.1        1.8  

Other related costs

     2.8        0.8  
  

 

 

    

 

 

 

Special charges, net

   $ 11.7      $ 5.3  
  

 

 

    

 

 

 

 

20


The integration of the industrial adhesives business we acquired in March 2012 involves a significant amount of restructuring and capital investment to optimize the new combined entity. In addition to this acquisition, we announced our intentions to take a series of actions in our existing EIMEA operating segment to improve the profitability and future growth prospects of this operating segment. We have combined these two initiatives into a single project which we refer to as the “Business Integration Project”. During the 13 weeks ended March 1, 2014 and March 2, 2013, we incurred special charges, net of $11.7 million and $5.3 million respectively, for costs related to the Business Integration Project.

Acquisition and transformation related costs of $1.7 million for the first quarter of 2014 and $2.2 million for the first quarter of 2013 include costs related to organization consulting, financial advisory and legal services necessary to integrate the acquired business into our existing operating segments. During the 13 weeks ended March 1, 2014, we incurred workforce reduction costs of $2.1 million, cash facility exit costs of $3.6 million and non-cash facility exit costs of $1.5 million and other incremental transformation related costs of $2.8 million including the cost of personnel directly working on the integration. During the 13 weeks ended March 2, 2013, we incurred workforce reduction costs of $0.5 million, cash facility exit costs of $1.4 million and non-cash facility exit costs of $0.4 million and other incremental transformation related costs of $0.8 million including the cost of personnel directly working on the integration.

The benefits of the Business Integration Project are expected to be substantial. We have plans to create annual cash cost savings and other cash pre-tax profit improvement benefits aggregating to $90.0 million when the various integration activities are completed in 2014. By 2015, the Business Integration Project activities are expected to improve the EBITDA margin of the global business from just under 11 percent in 2011 to a target level of 15 percent. The project incorporates many different work streams each of which has a specific timeline for completion and delivery of benefits. Taking the expected impact of all initiatives into account, the profit improvement benefits should drive steady annual improvement in EBITDA margin until the target level is achieved in 2015.

We estimated the total costs of the Business Integration Project to be approximately $125.0 million. Primarily due to delays in completing the EIMEA portion of the project, we expect total project costs will exceed this estimate by an immaterial amount. The following table provides detail of costs incurred inception-to-date as of March 1, 2014 for the Business Integration Project:

 

($ in millions)

   Costs Incurred
Inception-to-Date
as of March  1, 2014
 

Acquisition and transformation related costs

   $ 36.1  

Work force reduction costs

     40.0  

Cash facility exit costs

     16.4  

Non-cash facility exit costs

     10.8  

Other related costs

     13.5  
  

 

 

 

Business Integration Project

   $ 116.8  
  

 

 

 

The costs associated with the acquisition integration and the cash costs of the restructuring are incremental cash outlays that will be funded with existing cash and cash generated from operations. Non-cash costs are primarily related to accelerated depreciation of long-lived assets.

The capital expenditures related to the Business Integration Project are significant. In 2014, we expect to spend approximately $45.0 million to complete the Business Integration Project. This capital spending forecast, which is consistent with our original forecast, will be funded from the operating cash flows of the business and if necessary, from available cash and short-term borrowing.

When we report our progress on achieving our profit improvement initiatives each quarter we focus on three key metrics which capture the bulk of the Business Integration Project objectives: (1) cost savings achieved through workforce reductions, (2) cost reductions achieved through facility closures and consolidation and (3) the EBITDA margin of the business relative to our expected trend over the timeframe of the project.

 

21


For the quarter ended March 1, 2014, we achieved cost savings of $4.5 million related to workforce reductions and $0.9 million related to facility closures and consolidations. For the quarter ended March 2, 2013, we achieved cost savings of $3.6 million related to workforce reductions and $1.2 million related to facility closures and consolidations. The above cost savings represent benefits from selected activities included in the Business Integration Project. For the quarter ended March 1, 2014 and March 2, 2013, we achieved EBITDA margin of 10.5 percent and 10.6 percent, respectively.

Other income (expense), net:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
     2014 vs
2013
 

Other income (expense), net

   $ (1.1   $ 0.4        NMP   

NMP = Non-meaningful percentage

Other income (expense), net in the first quarter of 2014 included $1.3 million of currency translation and re-measurement losses offset by $0.1 million of net financing income and $0.1 million of interest income. Other income (expense), net in the first quarter of 2013 included $0.2 million of interest income and $0.2 million of currency translation and re-measurement gains.

Interest expense:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
     March 2,
2013
     2014 vs
2013
 

Interest expense

   $ 4.1      $ 5.3        (22.5 %) 

Interest expense in the first quarter of 2014 as compared to same period last year was lower due to higher capitalized interest related to the Business Integration Project and to lower average debt balances. We capitalized interest expense of $1.0 million in the first quarter of 2014 as compared to $0.1 million in the same period last year.

Income taxes:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

Income taxes

   $ 6.5     $ 7.1       (8.1 %) 

Effective tax rate

     33.8     28.0  

Income tax expense of $6.5 million in the first quarter of 2014 includes $0.2 million of discrete tax benefits and $2.3 million of tax benefits relating to special charges for costs related to the Business Integration Project. Excluding the discrete tax benefits and the effects of items included in special charges, the overall effective tax rate was 29.0 percent. Without discrete tax benefits of $0.8 million and the impact of costs related to the Business Integration Project in the first quarter of 2013, the overall effective tax rate was 29.4 percent.

Income from equity method investments:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
     March 2,
2013
     2014 vs
2013
 

Income from equity method investments

   $ 1.9      $ 2.4        (24.0 %) 

 

22


The income from equity method investments relates to our 50 percent ownership of the Sekisui-Fuller joint venture in Japan.

Net income attributable to non-controlling interests:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

Net income attributable to non-controlling interests

   $ (0.1   $ (0.1     NMP   

NMP = Non-meaningful percentage

Net income attributable to non-controlling interests relates to an 11 percent redeemable non-controlling interest in HBF Turkey.

Net income attributable to H.B. Fuller:

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

Net income attributable to H.B. Fuller

   $ 14.6     $ 20.7       (29.5 %) 

Percent of net revenue

     3.0     4.3  

The net income attributable to H.B. Fuller for the first quarter of 2014 was $14.6 million compared to $20.7 million for the first quarter of 2013. The first quarter of 2014 included $11.7 million of special charges, net ($9.4 million after tax) for costs related to the Business Integration Project. The first quarter of 2013 included $5.3 million of special charges, net ($4.2 million after tax) for costs related to the Business Integration Project. The diluted earnings per share for the first quarter of 2014 was $0.28 per share as compared to $0.41 per share for the first quarter of 2013.

Operating Segment Results

Through the third quarter of 2013, our business was reported in five operating segments: North America Adhesives, EIMEA (Europe, India, Middle East and Africa), Latin America Adhesives, Asia Pacific and Construction Products. Changes in our management reporting structure during the fourth quarter of 2013 required us to conduct an operating segment assessment in accordance with ASC Topic 280 “Segment Reporting”, to determine our reportable segments. As a result of this assessment, we now have four reportable segments: Americas Adhesives, EIMEA, Asia Pacific and Construction Products. Prior periods have been restated to reflect our new operating segments. Operating results of each of these segments are regularly reviewed by our chief operating decision maker to make decisions about resources to be allocated to the segments and assess their performance.

The tables below provide certain information regarding the net revenue and segment operating income of each of our operating segments. The pricing/sales volume variance is viewed as organic growth. For segment evaluation by the chief operating decision maker, segment operating income is defined as gross profit less SG&A expenses and excludes special charges, net.

Net Revenue by Segment:

 

     13 Weeks Ended  
     March 1, 2014     March 2, 2013  

($ in millions)

   Net
Revenue
     % of
Total
    Net
Revenue
     % of
Total
 

Americas Adhesives

   $ 209.7        43   $ 207.7        43

EIMEA

     171.6        35     177.5        37

Asia Pacific

     65.0        14     60.6        13

Construction Products

     39.7        8     34.0        7
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 486.0        100   $ 479.8        100
  

 

 

    

 

 

   

 

 

    

 

 

 

 

23


Segment Operating Income:

 

     13 Weeks Ended  
     March 1, 2014     March 2, 2013  

($ in millions)

   Segment
Operating
Income
     % of
Total
    Segment
Operating
Income
     % of
Total
 

Americas Adhesives

   $ 25.2        70   $ 25.9        73 %

EIMEA

     8.4        23     6.5        17 %

Asia Pacific

     1.8        5     2.0        6 %

Construction Products

     0.8        2     1.3        4 %
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 36.2        100   $ 35.7        100
  

 

 

    

 

 

   

 

 

    

 

 

 

The following table provides a reconciliation of segment operating income to income before income taxes and income from equity method investments, as reported on the Condensed Consolidated Statements of Income.

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
 

Segment operating income

   $ 36.2     $ 35.7  

Special charges, net

     (11.7     (5.3

Other income (expense), net

     (1.1     0.4  

Interest expense

     (4.1     (5.3
  

 

 

   

 

 

 

Income before income taxes and income from equity method investments

   $ 19.3     $ 25.5  
  

 

 

   

 

 

 

Americas Adhesives

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

Net revenue

   $ 209.7     $ 207.7       0.9

Segment operating income

   $ 25.2     $ 25.9       (2.8 %) 

Segment profit margin %

     12.0     12.5  

The following tables provide details of the Americas Adhesives net revenue variances:

 

     13 Weeks Ended March 1, 2014
vs March 2, 2013
 

Organic growth

     1.5

Currency

     (0.6 %) 
  

 

 

 

Total

     0.9
  

 

 

 

Net revenue increased 0.9 percent in the first quarter of 2014 compared to the first quarter of 2013. The 1.5 percent increase in organic growth was attributable to a 2.1 percent increase in sales volume partially offset by a 0.6 percent decrease in pricing. The weaker Canadian dollar compared to the U.S. dollar resulted in a 0.6 percent decrease in net revenue. As a percentage of net revenue, raw material cost increased 60 basis points compared to last year, mainly due to the mix of products sold. All other costs as a percentage of net revenue were unchanged. Segment operating income decreased 2.8 percent and segment profit margin as a percentage of net revenue decreased 50 basis points in the first quarter compared to the first quarter last year.

 

24


EIMEA

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

Net revenue

   $ 171.6     $ 177.5       (3.3 %) 

Segment operating income

   $ 8.4     $ 6.5       30.4

Segment profit margin%

     4.9     3.6  

The following table provides details of the EIMEA net revenue variances:

 

     13 Weeks Ended March 1, 2014
vs March 2, 2013
 

Organic growth

     (3.2 %) 

Currency

     (0.1 %) 
  

 

 

 

Total

     (3.3 %) 
  

 

 

 

Net revenue decreased 3.3 percent in the first quarter of 2014 compared to the first quarter of 2013. The negative organic growth of 3.2 percent was attributable to a 4.0 percent decrease in sales volume partially offset by 0.8 percent increase in pricing. The negative currency effect of 0.1 percent was a result of a weaker Turkish lira, Indian rupee and Egyptian pound partially offset by a stronger Euro compared to the U.S. dollar. Sales volume was down in core Europe reflecting the generally soft end market conditions across most of the region, especially in the southern region. Sales volume growth was generated in the emerging markets, mainly in India. Raw material cost as a percentage of net revenue decreased 160 basis points in the first quarter compared to the same quarter last year reflecting the benefits of the Business Integration Project. Manufacturing cost as a percentage of net revenue was 50 basis points higher than last year mainly due to business integration costs that are not classified as special charges. SG&A expenses as a percentage of net revenue declined 20 basis points relative to the prior year. As a result of the above factors, segment operating income increased 30.4 percent and segment profit margin increased 130 basis points compared to the first quarter last year.

Asia Pacific

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

Net revenue

   $ 65.0     $ 60.6       7.4

Segment operating income

   $ 1.8     $ 2.0       (9.4 %) 

Segment profit margin %

     2.7     3.3  

The following table provides details of Asia Pacific net revenue variances:

 

     13 Weeks Ended March 1, 2014
vs March 2, 2013
 

Organic growth

     10.8

Currency

     (3.4 %) 
  

 

 

 

Total

     7.4
  

 

 

 

Net revenue in the first quarter of 2014 increased 7.4 percent compared to the first quarter last year. The 10.8 percent increase in organic growth was attributable to a 9.4 percent increase in sales volume and a 1.4 percent increase in pricing. Markets in China, Australia and Korea showed growth while Southeast Asia markets were down compared with first quarter last year. Negative currency effects of 3.4 percent compared to last year are mainly attributable to Australia and Southeast Asia markets. Raw material costs as a percentage of net revenue increased 190 basis points compared to the first quarter of last year mainly due to sales mix. All other costs as a percentage of net revenue decreased 130 basis points compared to the first quarter of last year driven by effective cost controls. Compared to the first quarter of last year, segment operating income decreased $0.2 million and segment profit margin decreased 60 basis points.

 

25


Construction Products

 

     13 Weeks Ended  

($ in millions)

   March 1,
2014
    March 2,
2013
    2014 vs
2013
 

Net revenue

   $ 39.7     $ 34.0       16.7

Segment operating income

   $ 0.8     $ 1.3       (40.5 %) 

Segment profit margin %

     2.0     4.0  

The following tables provide details of the Construction Products net revenue variances:

 

     13 Weeks Ended March 1, 2014
vs March 2, 2013
 

Organic growth

     16.7

Net revenue increased 16.7 percent in the first quarter of 2014 compared to the first quarter 2013. The increase was driven by a 19.2 percent increase in sales volume partially offset by a 2.5 percent decrease in pricing. The increase in sales volume was primarily attributed to continued market share gains with several key retail partners. Raw material cost as a percentage of net revenue was approximately 140 basis points higher in the first quarter of 2014 compared to last year primarily due to changes in sales mix. All other costs as a percentage of net revenue increased 60 basis points compared to the first quarter of last year. Segment operating income decreased 40.5 percent and segment profit margin decreased 200 basis points in the first quarter compared to the same period last year.

Financial Condition, Liquidity and Capital Resources

Total cash and cash equivalents as of March 1, 2014 were $113.0 million as compared to $155.1 million as of November 30, 2013 and $163.1 million as of March 2, 2013. Of the $113.0 million in cash and cash equivalents as of March 1, 2014, $101.1 million was held outside the United States. Total long and short-term debt was $533.7 million as of March 1, 2014, $492.9 million as of November 30, 2013 and $511.0 million as of March 2, 2013. The total debt to total capital ratio as measured by Total Debt divided by (Total Debt plus Total Equity) was 36.4 percent as of March 1, 2014 as compared to 34.6 percent as of November 30, 2013 and 39.0 percent as of March 2, 2013.

We believe that cash flows from operating activities will be adequate to meet our ongoing liquidity and capital expenditure needs. In addition, we believe we have the ability to obtain both short-term and long-term debt to meet our financing needs for the foreseeable future. Cash available in the United States has historically been sufficient and we expect it will continue to be sufficient to fund U.S. operations and U.S. capital spending and U.S. pension and other post retirement benefit contributions in addition to funding U.S. acquisitions, dividend payments, debt service and share repurchases as needed. For those international earnings considered to be reinvested indefinitely, we currently have no intention to, and plans do not indicate a need to, repatriate these funds for U.S. operations.

Our credit agreements and note purchase agreements include restrictive covenants that, if not met, could lead to a renegotiation of our credit lines and a significant increase in our cost of financing. At March 1, 2014, we were in compliance with all covenants of our contractual obligations as shown in the following table:

 

Covenant

   Debt Instrument      Measurement      Result as of
March 1, 2014
 

TTM EBITDA / TTM Interest Expense

     All Debt Instruments         Not less than 2.5         13.4   

Total Indebtedness / TTM EBITDA

     All Debt Instruments         Not greater than 3.5         2.2   

 

26


    TTM = Trailing 12 months

 

    EBITDA for covenant purposes is defined as consolidated net income, plus (i) interest expense, (ii) taxes, (iii) depreciation and amortization, (iv) non-cash impairment losses, (v) extraordinary non-cash losses incurred other than in the ordinary course of business, (vi) nonrecurring extraordinary non-cash restructuring charges, (vii) cash expenses for advisory services and for arranging financing for the Forbo Acquisition (including the non-cash write-off of deferred financing costs and any loss or expense on foreign exchange transactions intended to hedge the purchase price for the Forbo acquisition) with cash expenses not to exceed $25.0 million, and (viii) cash expenses incurred during fiscal years 2011 through 2014 in connection with facilities consolidation, restructuring and integration, discontinuance of operations, work force reduction, sale or abandonment of assets other than inventory, and professional and other fees incurred in connection with the Forbo acquisition or the restructuring of our EIMEA operations, not to exceed $85.0 million in the aggregate, and (x) not to exceed $65.0 million during fiscal year 2012 and (y) not to exceed $65.0 million during fiscal years 2013 and 2014 combined, minus extraordinary non-cash gains incurred other than in the ordinary course of business. For the Total Indebtedness / TTM EBITDA ratio, TTM EBITDA is adjusted for the pro forma results from Material Acquisitions and Material Divestitures as if the acquisition or divestiture occurred at the beginning of the calculation period. Additional detail is provided in the Current Report on Form 8-K dated March 5, 2012.

We believe we have the ability to meet all of our contractual obligations and commitments in fiscal 2014.

Selected Metrics of Liquidity

Key metrics we monitor are net working capital as a percent of annualized net revenue, trade account receivable days sales outstanding (DSO), inventory days on hand, free cash flow and debt capitalization ratio.

 

     March 1,   March 2,
     2014   2013

Net working capital as a percentage of annualized net revenue

   19.5%   19.3%

Accounts receivable DSO

   56 Days   53 Days

Inventory days on hand

   65 Days   58 Days

Free cash flow

   $(73.0) million   $(35.4) million

Total debt to total capital ratio

   36.4%   39.0%

 

1 Current quarter net working capital (trade receivables, net of allowance for doubtful accounts plus inventory minus trade payables) divided by annualized net revenue (current quarter multiplied by four).
2 Trade receivables net of the allowance for doubtful accounts at the balance sheet date multiplied by 56 (8 weeks) and divided by the net revenue for the last 2 months of the quarter.
3 Total inventory multiplied by 56 and divided by cost of sales (excluding delivery costs) for the last 2 months of the quarter.
4  Year-to-date net cash provided by (used in) operations from continuing operations, less purchased property, plant and equipment and dividends paid.
5  Total debt divided by (total debt plus total stockholders’ equity).

Another key metric is the return on invested capital, or ROIC. The calculation is represented by total return divided by total invested capital.

    Total return is defined as: gross profit less SG&A expenses, less taxes at the effective tax rate plus income from equity method investments. Total return is calculated using trailing 12 month information.

 

    Total invested capital is defined as the sum of notes payable, current maturities of long-term debt, long-term debt, redeemable non-controlling interest and total equity.

We believe ROIC provides a true measure of return on capital invested and is focused on the long term. The following table shows the ROIC calculations based on the definition above:

 

27


     Trailing 12 months     Trailing 12 months  

($ in millions)

   as of March 1, 2014     as of March 2, 2013  

Gross profit

   $ 570.9     $ 548.0  

Selling, general and administrative expenses

     (373.8     (377.4

Income taxes at effective rate

     (57.4     (49.9

Income from equity method investments

     7.8       9.4  
  

 

 

   

 

 

 

Total return

   $ 147.5     $ 130.1  

Total invested capital

   $ 1,472.6     $ 1,315.7  

Return on invested capital

     10.0     9.9

Summary of Cash Flows

Cash Flows from Operating Activities from Continuing Operations:

 

     13 Weeks Ended  
     March 1,     March 2,  

($ in millions)

   2014     2013  

Net cash used in operating activities

   $ (17.1   $ (11.5

Net income including non-controlling interests was $14.6 million in the first three months of 2014 compared to $20.8 million in the first three months of 2013. Depreciation and amortization expense totaled $16.1 million in the first three months of 2014 compared to $15.6 million in the first three months of 2013. Accrued compensation was a use of cash of $22.8 million in 2014 compared to a use of cash of $18.6 million last year. The use of cash in both years is related to payments for our employee incentive plans in the first quarter and to the timing of payments of severance related costs for the Business Integration Project. Income taxes payable was a source of cash of $1.8 million in the first three months of 2014 compared to a use of cash of $9.1 million in same period last year. The source of cash in 2014 and use of cash in 2013 are related to the timing of income tax payments and accruals.

Changes in net working capital (trade receivables, inventory and trade payables) accounted for a use of cash of $17.7 million compared to a use of cash of $10.3 million last year. The table below provides the cash flow impact due to changes in the components of net working capital:

 

     13 Weeks Ended  
     March 1,     March 2,  

($ in millions)

   2014     2013  

Trade receivables, net

   $ 3.7     $ 11.3  

Inventory

     (38.7     (22.9

Trade payables

     17.3       1.3  
  

 

 

   

 

 

 

Total cash flow impact

   $ (17.7   $ (10.3
  

 

 

   

 

 

 

 

    Trade Receivables, net – Trade Receivables, net was a source of cash of $3.7 million in 2014 compared to a source of cash of $11.3 million in 2013. The lower source of cash in 2014 compared to 2013 is partially related to a higher DSO. The DSO was 56 days at March 1, 2014 and 53 days at March 2, 2013.

 

    Inventory – Inventory was a use of cash of $38.7 million and $22.9 million in 2014 and 2013, respectively. The use of cash in both years is related to the normal seasonal building of inventory and increased inventory to support the manufacturing transitions as part of the Business Integration Project. Inventory days on hand were 65 days as of March 1, 2014 and 58 days as of March 2, 2013.

 

    Trade Payables – For the first three months of 2014 trade payables was a source of cash of $17.3 million compared to a source of cash of $1.3 million in 2013. The higher source of cash in 2014 reflects the higher purchases of property, plant and equipment and purchases of inventory that had not been paid at the end of the first quarter.

 

28


Cash Flows from Investing Activities from Continuing Operations:

 

     13 Weeks Ended  
     March 1,     March 2,  

($ in millions)

   2014     2013  

Net cash used in investing activities

   $ (50.3   $ (17.7

Purchases of property, plant and equipment were $50.9 million in the first three months of 2014 as compared to $19.6 million for the same period of 2013. The increase in 2014 compared to 2013 was primarily related to capital expenditures for the Business Integration Project and Project ONE. In the first quarter of 2013, an adjustment of the purchase price for the Forbo industrial adhesives business acquisition reduced cash used in investing activities by $1.6 million.

Cash Flows from Financing Activities from Continuing Operations:

 

     13 Weeks Ended  
     March 1,      March 2,  

($ in millions)

   2014      2013  

Net cash provided by (used in) financing activities

   $ 24.6      $ (8.7

Proceeds from long-term debt in the first three months of 2014 were $40.0 million compared to $36.0 million in the first three months of 2013. Repayments of long-term debt were $43.5 million in the first three months of 2013. There were no repayments of long-term debt in the first three months of 2014. Cash generated from the exercise of stock options was $2.0 million and $3.8 million for the first three months of 2014 and 2013, respectively. Repurchases of common stock were $15.3 million in the first three months of 2014 compared to $2.3 million in the same period of 2013. The higher 2014 repurchases of common stock were due to $12.3 million of repurchases from our 2010 share repurchase program and higher repurchases related to statutory minimum tax withholding in conjunction with the vesting of restricted stock.

Cash Flows from Discontinued Operations:

 

     13 Weeks Ended  
     March 1,      March 2,  

($ in millions)

   2014      2013  

Net cash used in operating activities of discontinued operations

   $ —        $ (0.1

Cash flows from discontinued operations includes cash generated from operations of the Central America Paints business.

Forward-Looking Statements and Risk Factors

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements. In this Quarterly Report on Form 10-Q, we discuss expectations regarding our future performance which include anticipated financial performance, savings from restructuring and process initiatives, global economic conditions, liquidity requirements, the impact of litigation and environmental matters, the effect of new accounting pronouncements and one-time accounting charges and credits, and similar matters. This Quarterly Report on Form 10-Q contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words like “plan,” “expect,” “aim,” “believe,” “project,” “anticipate,” “intend,” “estimate,” “will,” “should,” “could” (including the negative or variations thereof) and other expressions that indicate future events and trends. These plans and expectations are based upon certain underlying assumptions, including those mentioned with the specific statements. Such assumptions are in turn based upon internal estimates and analyses of current market conditions and trends, our plans and strategies, economic

 

29


conditions and other factors. These plans and expectations and the assumptions underlying them are necessarily subject to risks and uncertainties inherent in projecting future conditions and results. Actual results could differ materially from expectations expressed in the forward-looking statements if one or more of the underlying assumptions and expectations proves to be inaccurate or is unrealized. In addition to the factors described in this report, Part II, Item 1A. Risk Factors in this report and Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended November 30, 2013, identify some of the important factors that could cause our actual results to differ materially from those in any such forward-looking statements. This list of important factors does not include all such factors nor necessarily present them in order of importance. In order to comply with the terms of the safe harbor, we have identified these important factors which could affect our financial performance and could cause our actual results for future periods to differ materially from the anticipated results or other expectations expressed in the forward-looking statements. Additionally, the variety of products sold by us and the regions where we do business makes it difficult to determine with certainty the increases or decreases in revenues resulting from changes in the volume of products sold, currency impact, changes in geographic and product mix and selling prices. Our best estimates of these changes as well as changes in other factors have been included. References to volume changes include volume, product mix and delivery charges, combined. These factors should be considered, together with any similar risk factors or other cautionary language, which may be made elsewhere in this Quarterly Report on Form 10-Q.

We may refer to Part II, Item 1A. Risk Factors and this section of the Form 10-Q to identify risk factors related to other forward looking statements made in oral presentations, including investor conferences and/or webcasts open to the public.

This disclosure, including that under “Forward-Looking Statements and Risk Factors,” and other forward-looking statements and related disclosures made by us in this report and elsewhere from time to time, represents our best judgment as of the date the information is given. We do not undertake responsibility for updating any of such information, whether as a result of new information, future events, or otherwise, except as required by law. Investors are advised, however, to consult any further public company disclosures (such as in filings with the Securities and Exchange Commission or in company press releases) on related subjects.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market Risk: We are exposed to various market risks, including changes in interest rates, foreign currency rates and prices of raw materials. Market risk is the potential loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates and cost of raw materials.

Our financial performance may be negatively affected by the unfavorable economic conditions. Recessionary economic conditions may have an adverse impact on our sales volumes, pricing levels and profitability. As domestic and international economic conditions change, trends in discretionary consumer spending also become unpredictable and subject to reductions due to uncertainties about the future. A general reduction in consumer discretionary spending due to recession in the domestic and international economies, or uncertainties regarding future economic prospects, could have a material adverse effect on our results of operations.

Interest Rate Risk: Exposure to changes in interest rates result primarily from borrowing activities used to fund operations. Committed floating rate credit facilities are used to fund a portion of operations. We believe that probable near-term changes in interest rates would not materially affect financial condition, results of operations or cash flows. The annual impact on interest expense of a one-percentage point interest rate change on the outstanding balance of our variable rate debt as of March 1, 2014 would be approximately $1.4 million or $0.03 per diluted share.

Foreign Exchange Risk: As a result of being a global enterprise, there is exposure to market risks from changes in foreign currency exchange rates, which may adversely affect operating results and financial condition. Approximately 59 percent of net revenue was generated outside of the United States for the first three months of 2014. Principal foreign currency exposures relate to the Euro, British pound sterling, Canadian dollar, Chinese renminbi, Japanese yen, Australian dollar, Argentine peso, Brazilian real, Columbian peso, Mexican peso, Turkish lira, Egyptian pound, Indian rupee and Malaysian ringgit.

Our objective is to balance, where possible, local currency denominated assets to local currency denominated liabilities to have a natural hedge and minimize foreign exchange impacts. We enter into cross border transactions through importing and exporting goods to and from different countries and locations. These transactions generate foreign exchange risk as they create assets, liabilities and cash flows in currencies other than the local currency. This also applies to services provided and other cross border agreements among subsidiaries.

 

30


We take steps to minimize risks from foreign currency exchange rate fluctuations through normal operating and financing activities and, when deemed appropriate, through the use of derivative instruments. We do not enter into any speculative positions with regard to derivative instruments.

From a sensitivity analysis viewpoint, based on the financial results of the first three months of 2014, and foreign currency balance sheet positions as of March 1, 2014, a hypothetical overall 10 percent change in the U.S. dollar would have resulted in a change in net income attributable to H.B. Fuller of approximately $1.4 million or $0.03 per diluted share.

Raw Materials: The principal raw materials used to manufacture products include resins, polymers, synthetic rubbers, vinyl acetate monomer and plasticizers. We generally avoid single source supplier arrangements for raw materials. While alternate supplies of most key raw materials are available, unplanned supplier production outages may lead to strained supply-demand situations for several key raw materials such as tackifyers and base polymers. There is also tightness in feed stream chemicals such as ethylene and propylene.

For the three months ended March 1, 2014, our single largest expenditure was the purchase of raw materials. Our objective is to purchase raw materials that meet both our quality standards and production needs at the lowest total cost. Most raw materials are purchased on the open market or under contracts that limit the frequency but not the magnitude of price increases. In some cases, however, the risk of raw material price changes is managed by strategic sourcing agreements which limit price increases to increases in supplier feedstock costs, while requiring decreases as feedstock costs decline. The leverage of having substitute raw materials approved for use wherever possible is used to minimize the impact of possible price increases.

Item 4. Controls and Procedures

(a) Controls and procedures

As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our president and chief executive officer and executive vice president, chief financial officer, of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (Exchange Act)). Based on this evaluation, the president and chief executive officer and the executive vice president, chief financial officer concluded that, as of March 1, 2014, our disclosure controls and procedures were effective (1) to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (2) to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to us, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in internal control over financial reporting

There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Environmental Matters. From time to time, we become aware of compliance matters relating to, or receive notices from, federal, state or local entities regarding possible or alleged violations of environmental, health or safety laws and regulations. We review the circumstances of each individual site, considering the number of parties involved, the level of potential liability or contribution of us relative to the other parties, the nature and magnitude of the hazardous substances involved, the method and extent of remediation, the estimated legal and consulting expense with respect to each site and the time period over which any costs would likely be incurred. Also, from time to time, we are identified as a “potentially responsible party” (PRP) under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) and/or similar state laws that impose liability for costs relating to the clean up of contamination resulting from past spills, disposal or other release of hazardous substances. We are also

 

31


subject to similar laws in some of the countries where current and former facilities are located. Our environmental, health and safety department monitors compliance with applicable laws on a global basis. To the extent we can reasonably estimate the amount of our probable liabilities for environmental matters, we establish a financial provision.

Currently we are involved in various environmental investigations, clean up activities and administrative proceedings and lawsuits. In particular, we are currently deemed a PRP in conjunction with numerous other parties, in a number of government enforcement actions associated with landfills and/or hazardous waste sites. As a PRP, we may be required to pay a share of the costs of investigation and clean up of these sites. In addition, we are engaged in environmental remediation and monitoring efforts at a number of current and former operating facilities. While uncertainties exist with respect to the amounts and timing of the ultimate environmental liabilities, based on currently available information, we have concluded that these matters, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow. However, adverse developments and/or periodic settlements could negatively impact the results of operations or cash flows in one or more future periods.

Other Legal Proceedings. From time to time and in the ordinary course of business, we are a party to, or a target of, lawsuits, claims, investigations and proceedings, including product liability, personal injury, contract, patent and intellectual property, environmental, health and safety, tax and employment matters. While we are unable to predict the outcome of these matters, we have concluded, based upon currently available information, that the ultimate resolution of any pending matter, individually or in the aggregate, including the asbestos litigation described in the following paragraphs, will not have a material adverse effect on our results of operations, financial condition or cash flow.

We have been named as a defendant in lawsuits in which plaintiffs have alleged injury due to products containing asbestos manufactured more than 30 years ago. The plaintiffs generally bring these lawsuits against multiple defendants and seek damages (both actual and punitive) in very large amounts. In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable injuries or that the injuries suffered were the result of exposure to products manufactured by us. We are typically dismissed as a defendant in such cases without payment. If the plaintiff presents evidence indicating that compensable injury occurred as a result of exposure to our products, the case is generally settled for an amount that reflects the seriousness of the injury, the length, intensity and character of exposure to products containing asbestos, the number and solvency of other defendants in the case, and the jurisdiction in which the case has been brought.

A significant portion of the defense costs and settlements in asbestos-related litigation is paid by third parties, including indemnification pursuant to the provisions of a 1976 agreement under which we acquired a business from a third party. Currently, this third party is defending and paying settlement amounts, under a reservation of rights, in most of the asbestos cases tendered to the third party.

In addition to the indemnification arrangements with third parties, we have insurance policies that generally provide coverage for asbestos liabilities (including defense costs). Historically, insurers have paid a significant portion of our defense costs and settlements in asbestos-related litigation. However, certain of our insurers are insolvent. We have entered into cost-sharing agreements with our insurers that provide for the allocation of defense costs and under certain circumstances, settlements and judgments, in asbestos-related lawsuits. Under these agreements, we are required under certain circumstances to fund a share of settlements and judgments allocable to years in which the responsible insurer is insolvent. In addition, to delineate our rights under certain insurance policies, in October 2009, we commenced a declaratory judgment action against one of our insurers in the United States District Court for the District of Minnesota. Additional insurers have been brought into the action to address issues related to the scope of their coverage. We recently entered into a settlement agreement with the defendant insurers in this case that provided for the allocation of defense costs and settlements in the future. The allocation under the settlement agreement depends on the outcome of an appeal of two issues to the United States Eighth Circuit Court of Appeals.

A summary of the number of and settlement amounts for asbestos-related lawsuits and claims is as follows:

 

     13 Weeks Ended      3 Years Ended  

($ in millions)

   March 1, 2014      March 2, 2013      November 30, 2013  

Lawsuits and claims settled

     2        —          22  

Settlement amounts

   $ 0.1      $ —        $ 1.4  

Insurance payments received or expected to be received

   $ 0.1      $ —        $ 1.1  

 

32


We do not believe that it would be meaningful to disclose the aggregate number of asbestos-related lawsuits filed against us because relatively few of these lawsuits are known to involve exposure to asbestos-containing products that we manufactured. Rather, we believe it is more meaningful to disclose the number of lawsuits that are settled and result in a payment to the plaintiff. To the extent we can reasonably estimate the amount of our probable liabilities for pending asbestos-related claims, we establish a financial provision and a corresponding receivable for insurance recoveries.

Based on currently available information, we have concluded that the resolution of any pending matter, including asbestos-related litigation, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow. However, adverse developments and/or periodic settlements could negatively impact the results of operations or cash flows in one or more future periods.

Item 1A. Risk Factors

This Form 10-Q contains forward-looking statements concerning our future programs, products, expenses, revenue, liquidity and cash needs as well as our plans and strategies. These forward-looking statements are based on current expectations and we assume no obligation to update this information. Numerous factors could cause actual results to differ significantly from the results described in these forward-looking statements, including the risk factors identified under Part I, Item 1A. Risk Factors contained in our Annual Report on Form 10-K for the fiscal year ended November 30, 2013. There have been no material changes in the risk factors disclosed by us under Part I, Item 1A. Risk Factors contained in the Annual Report on Form 10-K for the fiscal year ended November 30, 2013.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

Information on our purchases of equity securities during the first quarter follows:

 

Period

   (a)
Total
Number of
Shares
Purchased
     (b)
Average
Price
Paid per
Share
     (c)
Total Number
of Shares
Purchased as
Part of a
Publicly
Announced
Plan or
Program
     (d)
Maximum
Approximate
Dollar Value of
Shares that may
yet be Purchased
Under the  Plan or
Program
(millions)
 

December 1, 2013 - January 4, 2014

     337       $ 50.78        —        $ 74.2  

January 5, 2014 - February 1, 2014

     313,726       $ 48.86        250,000      $ 62.0  

February 2, 2014 - March 1, 2014

     —         $ —          —        $ 62.0  

 

1  The total number of shares purchased includes: (i) shares purchased under the board’s authorization described below and (ii) shares withheld to satisfy the employees’ withholding taxes upon vesting of restricted stock.

Repurchases of common stock are made to support our stock-based employee compensation plans and for other corporate purposes. Upon vesting of restricted stock awarded to employees, shares are withheld to cover the employees’ minimum withholding taxes.

On September 30, 2010, the Board of Directors authorized a new share repurchase program of up to $100.0 million of our outstanding common shares. Under the program, we are authorized to repurchase shares for cash on the open market, from time to time, in privately negotiated transactions or block transactions, or through an accelerated repurchase agreement. The timing of such repurchases is dependent on price, market conditions and applicable regulatory requirements. Upon repurchase of the shares, we reduced our common stock for the par value of the shares with the excess being applied against additional paid-in capital.

 

33


Item 6. Exhibits

 

31.1    Form of 302 Certification –James J. Owens
31.2    Form of 302 Certification –James R. Giertz
32.1    Form of 906 Certification –James J. Owens
32.2    Form of 906 Certification –James R. Giertz
101    The following materials from the H.B. Fuller Company Quarterly Report on Form 10-Q for the quarter ended March 1, 2014 formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Total Equity, (v) the Condensed Consolidated Statements of Cash Flows and (vi) the Notes to Condensed Consolidated Financial Statements.

 

34


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    H.B. Fuller Company
Dated: March 28, 2014       /s/ James R. Giertz
      James R. Giertz
      Executive Vice President,
      Chief Financial Officer

 

35


Exhibit Index

 

Exhibits     
31.1    Form of 302 Certification – James J. Owens
31.2    Form of 302 Certification – James R. Giertz
32.1    Form of 906 Certification –James J. Owens
32.2    Form of 906 Certification –James R. Giertz
101    The following materials from the H.B. Fuller Company Quarterly Report on Form 10-Q for the quarter ended March 1, 2014 formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Total Equity, (v) the Condensed Consolidated Statements of Cash Flows and (vi) the Notes to Condensed Consolidated Financial Statements.

 

36